The 100,000 sq ft scheme for client Cambridge Medipark will consist of a three-storey laboratory building and a four-storey office building, connected by an atrium link.

Works are due to begin on site this month with a scheduled completion date of late 2018.

Peter Young, Kier executive director, said: “This is another prestigious win for Kier in the biotech sector, building on our sector-leading expertise, as well as reaffirming our track record across Cambridge.

“Kier has extensive experience delivering specialist research facilities, and we are proud to be playing a key role in developing Cambridge Biomedical Campus – a world-renowned centre of clinical and healthcare excellence.”